Cargando…
Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients
Coronavirus 2 (SARS-CoV2) (COVID-19) causes severe acute respiratory syndrome. Severe illness of COVID-19 largely occurs in older people and recent evidence indicates that demented patients have higher risk for COVID-19. Additionally, COVID-19 further enhances the vulnerability of older adults with...
Autores principales: | Bartolomé, Fernando, Rosa, Luigi, Valenti, Piera, Lopera, Francisco, Hernández-Gallego, Jesús, Cantero, José Luis, Orive, Gorka, Carro, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083828/ https://www.ncbi.nlm.nih.gov/pubmed/35547737 http://dx.doi.org/10.3389/fimmu.2022.878201 |
Ejemplares similares
-
Standardizing salivary lactoferrin measurements to obtain a robust diagnostic biomarker for Alzheimer's disease
por: Bartolome, Fernando, et al.
Publicado: (2021) -
Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin
por: Carro, Eva, et al.
Publicado: (2017) -
Salivary Lactoferrin Expression in a Mouse Model of Alzheimer’s Disease
por: Antequera, Desiree, et al.
Publicado: (2021) -
Salivary lactoferrin as biomarker for Alzheimer's disease: Brain‐immunity interactions
por: Bermejo‐Pareja, Félix, et al.
Publicado: (2020) -
Decreased salivary lactoferrin levels are specific to Alzheimer's disease
por: González-Sánchez, Marta, et al.
Publicado: (2020)